February 19–21, 2025
Barcelona, Spain
Erica Moran Martinez
MICK® was proud to be part of SEMIPyP 2025, an important congress organized by the Society for the Study of Microbiota, Probiotics, and Prebiotics. With a program designed by the Scientific Committee to engage healthcare professionals, this year’s edition took a deep dive into the microbiome’s expanding role across medical disciplines.
Erica Moran Martinez, our Health Product Line Manager, attended the event to exchange ideas and explore research around microbiome modulation, prevention strategies, and therapeutic applications.
As understanding of the human microbiome continues to evolve, SEMIPyP remains a key event for staying informed and building strategic partnerships. MICK®’s participation reflects our ongoing investment in science-driven innovation and collaboration.
SEQUENTIA® BIOTECH SL
Barcelona
+34 930 107 368
* Sending the email implies acceptance of the Privacy Policy.
MICK® is co-founded by the European Union - grant agreement 190195702
European Union Funding H2020 Research and Innovation programme - grant agreement #868117
MICK® does not claim to diagnose, treat, cure, or prevent any disease. The information on the MICK® website is provided for informational purposes only and with the understanding that MICK® is not engaged in rendering medical advice or recommendations. You should not rely on any information on the website to diagnose or treat a health problem or condition or replace consultations with qualified health care professionals to meet your individual needs. Always check with your doctor for answers to your personal medical questions.
Copyright © Sequentia® Biotech 2024